Aptuit recognizes that the ultimate goal of API synthesis is to scale-up from milligram quantities at the lab bench to kilogram quantities in a pilot plant. We also understand that at the clinical supply stage, process development becomes increasingly complex. With over 220 combined years of experience at our Oxford, UK, site, 180 years at our Missouri, US, site, over 350 years at our Verona, Italy, site, and over 170 years' process chemistry experience in our senior staff in India, Aptuit's chemists are recognized as experts in process optimization for API scale up, as well as for novel route development. Aptuit's Oxford and Missouri facilities have been FDA inspected, and, additionally, the MHRA has inspected and approved the UK site.
At Aptuit, we can help you deal quickly and safely with the challenges and complexities of scale-up. Our staff and facilities work toward an API synthesis process that is:
- Robust and Reproducible
- Quick
- Transferable
- Cost-effective
- Safe
- Sustainable and Green
Our goal is to help you lock in your process parameters so that they may be transferred to any other facility as the product evolves in development. We can also produce batches of API, scaled to the specific demands of clinical trials.